全文获取类型
收费全文 | 5244篇 |
免费 | 432篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 103篇 |
妇产科学 | 144篇 |
基础医学 | 952篇 |
口腔科学 | 104篇 |
临床医学 | 524篇 |
内科学 | 964篇 |
皮肤病学 | 184篇 |
神经病学 | 783篇 |
特种医学 | 196篇 |
外科学 | 488篇 |
综合类 | 44篇 |
一般理论 | 4篇 |
预防医学 | 348篇 |
眼科学 | 138篇 |
药学 | 273篇 |
中国医学 | 8篇 |
肿瘤学 | 395篇 |
出版年
2024年 | 21篇 |
2023年 | 104篇 |
2022年 | 161篇 |
2021年 | 240篇 |
2020年 | 169篇 |
2019年 | 218篇 |
2018年 | 245篇 |
2017年 | 193篇 |
2016年 | 251篇 |
2015年 | 252篇 |
2014年 | 280篇 |
2013年 | 319篇 |
2012年 | 506篇 |
2011年 | 480篇 |
2010年 | 239篇 |
2009年 | 221篇 |
2008年 | 311篇 |
2007年 | 257篇 |
2006年 | 260篇 |
2005年 | 239篇 |
2004年 | 168篇 |
2003年 | 181篇 |
2002年 | 136篇 |
2001年 | 19篇 |
2000年 | 14篇 |
1999年 | 14篇 |
1998年 | 26篇 |
1997年 | 23篇 |
1996年 | 17篇 |
1995年 | 11篇 |
1994年 | 14篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1983年 | 5篇 |
1981年 | 4篇 |
1979年 | 3篇 |
1976年 | 3篇 |
1972年 | 2篇 |
1964年 | 2篇 |
1962年 | 2篇 |
1961年 | 2篇 |
1933年 | 4篇 |
1931年 | 2篇 |
1926年 | 5篇 |
排序方式: 共有5685条查询结果,搜索用时 0 毫秒
51.
52.
53.
54.
55.
Macrophage inflammatory protein-1alpha (MIP-1alpha) is an interesting chemokine because in addition to its variety proinflammatory activities including chemotaxis and immunomodulation, it is a potent inhibitor of hematopoetic stem cell proliferation. Inhibition of erythroid progenitor cells due to MIP-1alpha or other cytokines can play a role in the pathogenesis of anemia which is one of the most common extra-articular features of active rheumatoid arthritis (RA). In 84 patients with RA, serological and immunological parameters were assessed to detect inflammatory mechanisms and anemia in relation to the serum concentrations of MIP-1alpha. All patients fulfilled the ACR criteria for the diagnosis of a definite or classic RA. We used a quantitative enzyme immuno assay for the detection of MIP-1alpha as well as for the measurement of the acute phase protein serum amyloid A (SAA), the erythropoiesis inducer erythropoietin (EPO) and the transferrin receptor (TfR). The immune activation marker neopterin was measured radioimmunologically. Half of the patients with RA were anemic with hemoglobin values below 12 g/dl. MIP-1alpha was found to be elevated significantly in serum of patients with active rheumatoid arthritis and in patients with anemia. Most of the anemic patients with markedly elevated acute phase reactions had an anemia with chronic diseases and not a functional iron deficiency alone. TfR correlated with EPO. The results show that enhanced expression of MIP-1alpha is indicative of systemic inflammation in RA. Moreover, besides the regulation of inflammatory processes, this chemokine may influence the pathogenesis of anemia in RA patients. 相似文献
56.
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses 总被引:2,自引:0,他引:2
Hipp MM Hilf N Walter S Werth D Brauer KM Radsak MP Weinschenk T Singh-Jasuja H Brossart P 《Blood》2008,111(12):5610-5620
The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cells (DCs) and the induction of primary immune responses in vivo. Sorafenib, but not sunitinib, inhibits function of DCs, characterized by reduced secretion of cytokines and expression of CD1a, major histocompatibility complex, and costimulatory molecules in response to TLR ligands as well as by their impaired ability to migrate and stimulate T-cell responses. These inhibitory effects are mediated by inhibition of PI3 and MAP kinases and NFB signaling. In contrast, sorafenib had no influence on the phenotype and proliferation of T cells. To analyze the effects of both TKIs on cytotoxic T-cell induction in vivo, C57BL/6 mice were pretreated with sorafenib or sunitinib and immunized with OVA257-264 peptide. Sorafenib, but not sunitinib, application significantly reduced the induction of antigen-specific T cells. Numbers of regulatory T cells were reduced in peripheral blood mononuclear cells from mice treated with sunitinib. These results indicate that sunitinib, but not sorafenib, is suitable for combination with immunotherapeutic approaches for treatment of cancer patients. 相似文献
57.
58.
A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis 总被引:5,自引:0,他引:5
Taylor WJ Marchesoni A Arreghini M Sokoll K Helliwell PS 《Seminars in arthritis and rheumatism》2004,34(3):575-584
OBJECTIVE: To compare the accuracy of published classification criteria for the diagnosis of psoriatic arthritis (PsA) and to see whether data-derived classification criteria would be more accurate. METHODS: Data were abstracted from case-note review and radiographic review of patients identified with PsA or rheumatoid arthritis (RA) from 2 clinical disease registers. Each patient was classified according to 7 criteria sets. The test performance characteristics were compared using conditional logistic regression analysis. In an attempt to overcome the problems of the diagnostic gold standard, latent class analysis also was used to calculate test-performance characteristics. Classification and regression-tree methodology was used to derive new criteria and to indicate the diagnostic importance of particular data items, especially rheumatoid factor (RF). RESULTS: Four hundred ninety-nine patients were identified with RA (n=156) or PsA (n=343). Excluding the criteria of Fournie, which could not be applied in 24% of subjects, 446 cases could be classified by all of the other 6 methods. The most sensitive criteria for the diagnosis of PsA were those of Vasey and Espinoza, McGonagle, and Gladman (99%), whereas the others were significantly less sensitive (between 56% and 94%). The specificity of the criteria was high and statistically similar (between 93% and 99%). The Fournie criteria were the most difficult to use, whereas the Vasey and Espinoza and Moll and Wright criteria were the easiest (98% of subjects were able to be classified). A 2-latent class model found very similar test-performance characteristics. Logistic regression and classification and regression-tree models suggested that negative RF was not necessary for diagnosis in the presence of other characteristic features of PsA. CONCLUSIONS: Apart from the Bennett and European Spondyloarthropathy Study Group criteria, which have inadequate sensitivity, the published classification criteria for PsA have similar test-performance characteristics. These data suggest that the criteria proposed by Vasey and Espinoza, Gladman, or McGonagle are the most accurate and feasible in distinguishing between PsA and RA. Relevance International agreement about classification criteria for PsA will assist the interpretation of clinical and epidemiologic research. However, further prospective studies on unselected patients with and without PsA, including controls with non-rheumatoid inflammatory arthritis, are required to confirm these findings. 相似文献
59.
Regulation of cell growth and expression of 7B2, PC2, and PC1/3 by TGFbeta 1 and sodium butyrate in a human pituitary cell line (HP75) 总被引:1,自引:0,他引:1
Recent studies have shown that 7B2 and the neuroendocrine-specific proconvertase PC2 have important roles in pituitary cell
proliferation and hormone secretion. Studies from our laboratory have also shown that TGFb1 regulates anterior pituitary cell
proliferation and hormone secretion.
To study the regulation of 7B2 in human pituitary tumors, we used a cell line derived from a human pituitary adenoma (HP75)
that has been shown to express 7B2, PC1, PC2, and TGFβ receptors to analyze the effects of TGFβ1 and the histone deacetylase
inhibitor (HDACI) sodium butyrate (NaB) treatment on 7B2 mRNA expression along with the neuroendocrine-specific proconvertases
1/3 (PC1) and PC2 mRNA and protein expression. RNA was quantified by real-time PCR and proteins were detected by immunohistochemistry
and Western blotting.
Treatment of cells with 1 mM NaB or 1 nM TGFβ1 for 4 d decreased cell proliferation with a concomitant increase in the cell cycle protein p21. Real-time PCR analysis
showed a significant increase in 7B2 mRNA after NaB and TGFβ1 treatment. PC2 mRNA was down regulated by NaB while PC1 mRNA
was unchanged. TGFβ1 stimulated PC1, but not PC2 mRNA levels. Changes in PC1 and PC2 protein were similar to changes in the
mRNAs, but the differences were not significant.
These results indicated that NaB and TGFβ1 inhibit pituitary cell proliferation and regulate the expression of 7B2, PC1, and
PC2 in a cell culture model of pituitary tumors. Our results also indicate that inhibition of pituitary cell proliferation
is associated with increased expression of 7B2 mRNA. 相似文献
60.
Parents' Challenges and Physicians' Tasks in Disclosing Cancer to Children. A Qualitative Interview Study and Reflections on Professional Duties in Pediatric Oncology 下载免费PDF全文